Haruko Shima

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 13

Top Topics

Chronic Myeloid Leukemia

Stem Cell Transplantation

Tyrosine Kinase

Top Venues

Pediatric blood & cancer

International journal of hematology

Pediatrics international : official journal of the Japan Pediatric Society

Journal of pediatric hematology/oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Haruko Shima, Torataro Takaki, Jumpei Ito, Yu Iwabuchi, Atsuko Nakazawa, Hiroyuki Shimada
Refractory Burkitt Lymphoma With False-positive and False-negative Mass Detected on Positron Emission Tomography-Computed Tomography After Chemotherapy. Journal of pediatric hematology/oncology (2023)
Haruko Shima, Satomi Sato, Tetsuya Takimoto, Michiko Sakai, Noriko Hashida, Kyohei Isshiki, Hiroyuki Shimada
Neurocognitive outcomes of children with osteosarcoma treated with methotrexate. Pediatrics international : official journal of the Japan Pediatric Society 65 (1) (2023)
Haruko Shima, Satomi Sato, Tetsuya Takimoto, Michiko Sakai, Noriko Hashida, Kyohei Isshiki, Hiroyuki Shimada
Neurocognitive outcomes of children with osteosarcoma treated with methotrexate. Pediatrics international : official journal of the Japan Pediatric Society (2023)
Haruko Shima, Hiroyuki Shimada
Recent progress in the management of pediatric chronic myeloid leukemia. International journal of hematology 117 (2) (2022)
Haruko Shima, Akiko Kada, Akihiko Tanizawa, Iori Sato, Chikako Tono, Masaki Ito, Yuki Yuza, Akihiro Watanabe, Kiyoko Kamibeppu, Hideko Uryu, Katsuyoshi Koh, Chihaya Imai, Nao Yoshida, Yuhki Koga, Naoto Fujita, Akiko M Saito, Souichi Adachi, Eiichi Ishii, Hiroyuki Shimada
Discontinuation of tyrosine kinase inhibitors in pediatric chronic myeloid leukemia. Pediatric blood & cancer 69 (8) (2022)
Haruko Shima, Hiroyuki Shimada
Recent progress in the management of pediatric chronic myeloid leukemia. International journal of hematology (2022)
Haruko Shima, Hiroyuki Shimada
Recent progress in the management of pediatric chronic myeloid leukemia. International journal of hematology 117 (2) (2022)
Haruko Shima, Hiroyuki Shimada
Recent progress in the management of pediatric chronic myeloid leukemia. International journal of hematology 117 (2) (2022)
Haruna Yoshikawa, Takeshi Sato, Takahiro Ishikawa, Jumpei Ito, Fumito Yamazaki, Haruko Shima, Misa Honda, Hironori Shibata, Tomohiro Ishii, Hiroshi Asanuma, Hiroyuki Shimada, Tomonobu Hasegawa
Potential benefits of rapid genetic testing for germline WT1 in infants with bilateral renal tumors: A case report. Pediatric blood & cancer (2021)
Haruko Shima, Jumpei Ito, Kyohei Isshiki, Kanako Mitsui-Sekinaka, Fumito Yamazaki, Hiroyuki Shimada
Testicular involvement without testicular enlargement in a young male with atypical chronic myeloid leukemia. Pediatric blood & cancer 66 (10) (2019)
Jumpei Ito, Haruko Shima, Kyohei Inoue, Fumito Yamazaki, Hiroyuki Shimada
Haploidentical stem cell transplantation with posttransplant cyclophosphamide for refractory systemic juvenile xanthogranuloma. Pediatric blood & cancer 66 (10) (2019)
Hidemitsu Kurosawa, Akihiko Tanizawa, Hideki Muramatsu, Chikako Tono, Akihiro Watanabe, Haruko Shima, Masaki Ito, Yuki Yuza, Kazuko Hamamoto, Noriko Hotta, Masahiko Okada, Akiko Moriya Saito, Atsushi Manabe, Shuki Mizutani, Souichi Adachi, Keizo Horibe, Eiichi Ishii, Hiroyuki Shimada
Sequential use of second-generation tyrosine kinase inhibitors following imatinib therapy in pediatric chronic myeloid leukemia: A report from the Japanese Pediatric Leukemia/Lymphoma Study Group. Pediatric blood & cancer 65 (12) (2018)
Haruko Shima, Yuji Yamada, Hiroshi Asanuma, Hiroyuki Shimada
High-dose chemotherapy without whole lung radiation for refractory pulmonary metastases in an infant with stage IV favorable histology Wilms tumor. Pediatric blood & cancer 65 (8) (2018)